Close
Subscribe
Share
Innovations that take your diagnostic confidence to the next level
Siemens Ultrasound RSNA 2009 Highlights
- Significant advancements in Tissue Strain Analytics, contrast agent imaging and new volume applications for OB/GYN on the Siemens ACUSON S2000™ ultrasound platform
- Expanded clinical applications for the ACUSON X300™ ultrasound system, Premium Edition (PE) including contrast agent imaging
- The revolutionary ACUSON S2000™ Automated Breast Volume Scanner (ABVS)
ACUSON S2000 ultrasound system
Siemens’ implementations of Acoustic Radiation Force Impulse (ARFI) technology, Virtual Touch™ Tissue Imaging1 and Virtual Touch™ Tissue Quantification1 have been further optimized on the ACUSON S2000 ultrasound system. These leading-edge technologies add a new dimension to the diagnostic process by interrogating and measuring the stiffness of tissue which may be correlated with pathology. Virtual Touch Tissue Quantification is the first application to provide a numerical value related to tissue stiffness at a precise anatomical location which is promising in identifying early stages of liver diseases causing cirrhosis.
The ACUSON S2000 system integrates advancements in Cadence™ contrast pulse sequencing technology providing highly sensitive agent detection with outstanding enhancement uniformity, high frame rates, and a range of frequencies and transducers to suite your workflow.
The clinical applications of the ACUSON S2000 system for OB/GYN has been expanded to include skeletal rendering, which uniquely provides detailed visualization of the fetal skeleton through 3D data rendering.
ACUSON X300 Premium Edition
Expanded clinical applications for the ACUSON X300 PE will be previewed at RSNA 2009. New transducers include the 4V1c designed to address the technically difficult to image cardiac exam. The system will also feature contrast agent imaging for abdominal applications.
Automated Breast Volume Ultrasound
Siemens will also feature automated breast volume ultrasound with the ACUSON S2000 ABVS system. Automated breast volume scanning takes the operator dependence and variability out of breast ultrasound, while at the same time streamlining workflow with an acquisition time significantly less than handheld scanning. Never-before-seen views of the breast such as the anatomical coronal view increase diagnostic confidence. Comprehensive BI-RADS® semi-automated reporting capabilities further enhance the clinical workflow.
1 - Not commercially available in the U.S.A.
2- At the time of publication, the U.S. Food and Drug Administration has cleared ultrasound contrast agents only for use in LVO. Check the current regulation for the country in which you are using this system for contrast agent clearance.
